Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells | Zendy

Si Hyoung Kim | Zendy; Jun Goo Kang | Zendy; Chul Sik Kim | Zendy; Sung-Hee Ihm | Zendy; Moon Gi Choi | Zendy; Hyung Joon Yoo | Zendy; Seong Jin Lee | Zendy

Open Access

Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells

Author(s) -

Si Hyoung Kim,

Jun Goo Kang,

Chul Sik Kim,

Sung-Hee Ihm,

Moon Gi Choi,

Hyung Joon Yoo,

Seong Jin Lee

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-3101

Subject(s) - histone deacetylase inhibitor , microbiology and biotechnology , cancer research , apoptosis , biology , hsp90 inhibitor , protein kinase b , heat shock protein , survivin , histone deacetylase , chemistry , hsp90 , histone , biochemistry , gene

The influence of the novel heat shock protein 90 (hsp90) inhibitor NVP-AUY922 (AUY922) on anaplastic thyroid carcinoma (ATC) cells has not been investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research